Antioxidant strategies for neurodegenerative diseases

Bibliography

• HARMAN D: Aging: a theory based on free radical and radiation chemistry. J Gerontol. (1956) 11:298–300.
   PubMedGoogle Scholar
• HARMAN D: The biological clock: the mitochondria. J. Am. Geriatr. Soc. (1972) 20:145–147.
   PubMed Web of Science ®Google Scholar
• ORR WC, SOHAL RS: Extension of life span by overex-pression of superoxide dismutase and catalase in Drosophila melanogaster. Science (1994) 263:1128–1130.
   PubMed Web of Science ®Google Scholar
• SOHAL RS, WEINDRUCK R: Oxidative stress, caloric restriction and aging. Science (1996) 273:59–63.
   PubMed Web of Science ®Google Scholar
• BARJA G: Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity and relation to aging and longevity. J Bioenerg. Biomembr. (1999) 31:347–366.
   PubMed Web of Science ®Google Scholar
• SASTRE J, PALLARDO FV, VINA J: Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life (2000) 49:427–435.
   PubMed Web of Science ®Google Scholar
• ••An up-to-date review on pathological consequences ofoxidative stress in mitochondria.
   Google Scholar
• SASTRE J, PALLARDO FV, GARCIA DE LA ASUNCION J, VINA J: Mitochondria, oxidative stress and aging. Free Rad. Res. (2000) 32:189–198.
   PubMed Web of Science ®Google Scholar
• FLOOR E, WETZEL MJ: Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. (1998) 70:268–275.
   PubMed Web of Science ®Google Scholar
• CORDOSO-PELAEZ F, SONG S, PARTHASARATHY A,HAZZI C, NAIDU K, SANCHEZ-RAMOS J: Oxidative DNA damage in the aging mouse brain. Mov. Disord. (1999) 14:972–980.
   PubMedGoogle Scholar
• CARDOSO-PALAEZ F, BROOKS PJ, STEDEFORD T, SONG S, SANCHEZ-RAMOS J: DNA damage, repair and antioxi-dant systems in brain regions: a correlative study. Free Rad. Biol. Med. (2000) 28:779–785.
   PubMedGoogle Scholar
• ALBERS DS, BEAL MF: Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative diseases. J. Neural Transm. Suppl. (2000) 59133–154.
   Google Scholar
• •An interesting review on evidence for oxidative damage in several neurodegenerative diseases.
   Google Scholar
• SCHULZ JB, LINDENAU J, SEYFRIED J, DICHGANS J: Glutathione, oxidative stress and neurodegeneration. Eur.J. Biochem. (2000) 267:4904–4911.
   PubMedGoogle Scholar
• ••A concise but informative review on the role of glutathionedepletion in neurodegenerative diseases related to oxidative stress.
   Google Scholar
• ALMAGUER-MELLAN W, CRUZ-AGUADO R, BERGADO JA: Synaptic plasticity is impaired in rats with a low glutathione content. Synapse (2000) 38:369–374.
   PubMedGoogle Scholar
• PRATICO D, DELANTY N: Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am. J Med. (2000) 109:577–585.
   PubMed Web of Science ®Google Scholar
• ••A very interesting review on evidences for oxidative injuriesin AD as well as on results and perspectives of antioxidant treatments.
   Google Scholar
• MAYEUX R, SANO M: Treatment of Alzheimer's disease. N Engl. J. Med. (1999) 341:1670–1679.
   PubMed Web of Science ®Google Scholar
• PAPOLLA MA, CHYAN YJ, OMAR RA et al: Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol (1998) 152:871–877.
   PubMedGoogle Scholar
• SMITH MA, HIRAI K, HSIAO K etal: Arnyloid-beta deposi-tion in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. (1998) 70:2212–2215.
   PubMed Web of Science ®Google Scholar
• EMILIEN G, MALATEAUX J-M, BEYREUTHER K, MASTERSCL: Alzheimer's disease. Mouse models pave the way for therapeutic opportunities. Arch. Neurol. (2000) 57:176–181.
   Google Scholar
• EMILIEN G, BEYREUTHER K, MASTERS CL, MALOTEAUX JM: Prospects for pharmacological intervention in Alzheimer's disease. Arch. Neurol. (2000) 57:454–459.
   PubMedGoogle Scholar
• LE BARS PL, KATZ MM, BERMAN N et al.: A placebo-controlled, double-blind, randomized trial of an extract of Gingko biloba for dementia. JAMA (1997) 278:1327–1332.
   PubMed Web of Science ®Google Scholar
• SANO M, ERNESTO C, THOMAS RG et al.: A controlledtrial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl. J. Med. (1997) 336:1216–1222.
   PubMed Web of Science ®Google Scholar
• GUTZMANN H, HADLER D: Sustained efficacy and safetyof idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study. J Neural Transm. (1998) 54 (Suppl.) :301–310.
   Google Scholar
• GRUNDMAN M: Vitamin E and Alzheimer's disease: thebasis for additional clinical trials. Am. J Clin. Nutr. (2000) 71:630–636.
   Google Scholar
• DELANTY N, DICHTER MA: Antioxidant therapy in neurologic diseases. Arch. Neurol. (2000) 57:1265–1270.
   PubMed Web of Science ®Google Scholar
• WONG BS, PANT, LIU T et al.: Prion disease: a loss of antioxidant function? Biochem. Biophys. Res. Comm. (2000) 275:249–252.
   PubMedGoogle Scholar
• HENDERSON JT, JAVAHERI M, KOPKO M, RODER JC: Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-cysteine. j Neurosci. (1996) 16:7574–7582.
   PubMed Web of Science ®Google Scholar
• DRINGEN R, HAMPRECHT B: N-Acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonic rat brain. Neurosci. Lett. (1999) 259:79–82.
   PubMed Web of Science ®Google Scholar
• MARTINEZ M, MARTINEZ N, HERNANDEZ Al, FERRANDIZ ML: Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease? Life Sci. (1999) 64:1253–1257.
   Google Scholar
• CALABRESE V, BATES TE, STELLA AM: NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem. Res. (2000) 25:1315–1341.
   PubMed Web of Science ®Google Scholar
• CONTESTABILE A: Roles of NMDA receptor activity andnitric oxide production in brain development. Brain Res. Rev. (2000) 32:476–509.
   PubMedGoogle Scholar
• CHIUEH CC: Neuroprotective properties of nitricoxide. Ann. NY Acad. Sci. (1999) 890:301–311.
   PubMed Web of Science ®Google Scholar
• CIANI E, BALDINOTTI I, CONTESTABILE A: Sustained,chronic inhibition of nitric oxide synthase aggravates the neural damage in some excitotoxic models of brain injury. Brain Res. (2001): Submitted.
   Google Scholar
• BEHL C, MOOSMANN B, MANTHEY D, HECK S: The female sex hormone oestrogen as neuroprotectant: activities at various levels. Novartis Found. Symp. (2000) 230:234–238.
   Google Scholar
• ROTH A, SCHAFFNER W, HERTEL C: Phytoestrogenkaempferol (3,4',5,7-tetrahydroflavone) protects pc12 and T47D cells from beta-amyloid-induced toxicity. J Neurosci. Res. (1999) 57:399–404.
   PubMed Web of Science ®Google Scholar
• BASTIANETTO S, ZHENG WH, QUIRION R: Neuroprotec-tive abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured h ip p o camp al neur ons. Br. J. Pharmacol. (2000) 131:711–720.
   PubMed Web of Science ®Google Scholar
• VIRGILI M, CONTESTABILE A: Partial neuroprotection ofin vivo excitotoxic brain damage by chronic admini-stration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. (2000) 281:123–126.
   PubMed Web of Science ®Google Scholar
• DE RUVO C, AMODIO R, ALGERI S et al.: Nutritional antioxidants as antidegenerative agents. Int. J Dev. Neurosci. (2000) 18:359–66.
   PubMedGoogle Scholar
• ERDEN I, KAHRAMAN A: The protective effect of flavonol quercetin against ultraviolet induced oxidative stress in rats. Toxicology (2000) 154:21–29.
   PubMed Web of Science ®Google Scholar
• KNEKT P, ISOTUPA S, RISSANEN H et al.: Quercetin intake and the incidence of cerebrovascular diseases. Eur. j Clin. Nutr. (2000) 54:415–417.
   PubMed Web of Science ®Google Scholar
• WU BY, YU AC: Quercetin inhibits c-fos, heat shock protein and glial fibrillary acidic protein expression in injured astrocytes.j Neurosci. Res. (2000) 62:730–736.
   PubMed Web of Science ®Google Scholar
• HAMPSON AJ, GRIMALDI M, LOLIC M, WINK D, ROSENTHAL R, AXELROD J: Neuroprotective antioxi-dants from marijuana. Ann. NY Acad. Sci. (2000) 899:274–282.
   PubMed Web of Science ®Google Scholar
• CLEMENS JA: Cerebral ischemia: gene activation, neuronal injury and the protective role of antioxi-dants. Free Rad. Biol. Med. (2000) 28:1526–1531.
   PubMedGoogle Scholar
• BASTIANETTO S, RAMASSAMY C, DORE S, CHRISTEN Y, POIRIER J, QUIRION R: The Gingko biloba extract (Egb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur. J. Neurosci. (2000) 12:1882–1890.
   PubMed Web of Science ®Google Scholar
• LOGANI S, CHEN MC, TRAN T, LE T, RAFFA RB: Action of Gingko biloba related to potential utility for the treatment of conditions involving cerebral hypoxia. Life Sci. (2000) 67:1389–1396.
   PubMedGoogle Scholar
• WEI T, NI Y, HOU J, CHEN C, ZHAO B, XIN W: Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: protection by Gingko biloba extract. Pharmacol. Res. (2000) 41:427–433.
   PubMed Web of Science ®Google Scholar
• CABRERA J, REITER RJ, TAN DX et al: Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology (2000) 39:507–514.
   PubMed Web of Science ®Google Scholar
• LEE Y, LEE S, KIM C: Melatonin attenuates the changesin polyamine levels induced by systemic kainate administration in rat brains. J Neurol. Sci. (2000) 178:124–131.
   PubMed Web of Science ®Google Scholar
• KIM HC, JHOO WK, BING G et al.: Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. (2000) 874:15–23.
   PubMed Web of Science ®Google Scholar
• KNUCKEY NW, PALM D, PRIMIANO M, EPSTEIN MH, JOHANSON CE: N-acetylcysteine enhances hippo camp al neuronal survival after transient forebrain ischemia in rats. Stroke (1995) 26:305–310.
   PubMed Web of Science ®Google Scholar
• BRAHMA B, FORMAN RE, STEWART EE, NICHOLSON C, RICE ME: Ascorbate inhibits edema in brain slices. J Neurochem. (2000) 74:1263–1270.
   PubMedGoogle Scholar